All the Active Ingredient Drugs
Varicella Zoster Vaccines. Varicella Zoster Virus Vaccines 50 mcg/ 0.5 ml. 50 mcg/0.5 ml
Vials. Powder and susp. for IM inj.1/10 X 0.5 ml
Vaccination sched. consists of 2 doses of 0.5 mL each: an initial dose followed by a second dose 2 months later.
Prevent. of herpes zoster (HZ) and post-herpetic neuralgia (PHN), in
adults 50 years of age or older and adults 18 years of age or older at incr. risk of HZ.
C/I: Hypersens.
Varicella Zoster Vaccines. Varicella Zoster Virus Vaccines 19,400 PFU/0.65 ml. PRE-FILLED SYR. (PWDR + SOLV. for INJ.):
0.65 ml.
S.C. a single dose (0.65 ml), prefer.
in the deltoid region. Do not inject
intravascularly.
Prevention of herpes zoster (shingles) in
pts. 50 yrs of age and older.
C/I: Hypersens. to the product, to any of
the excip. (e.g., neomycin);
Primary/ acquired immunodef. states;
Immunosuppress. ther. (incl. high-dose
corticoster.), however, it is not C/I for use
in pts. who are receiv. topical/inhaled
corticoster. or low-dose syst. corticoster.
or in pts. who are receiv. corticosteroids
as replacem. ther. Active untreated tuberculosis; Pregn.
and should be avoided for 1 mnth foll.
vaccine.
